ALDX: Aldeyra Therapeutics Inc
今日ALDX汇率已更改4.99%。当日,交易品种以低点4.22和高点4.74进行交易。
关注Aldeyra Therapeutics Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ALDX新闻
- Aldeyra Therapeutics首席开发官将于2026年3月前离职
- Aldeyra Therapeutics chief development officer to step down by March 2026
- Aldeyra Therapeutics: Reproxalap’s March 2026 FDA Decision Is The Defining Catalyst
- Why Is Aldeyra Therapeutics Stock Falling Tuesday? - Aldeyra Therapeutics (NASDAQ:ALDX)
- Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - Adagio Medical Holdings (NASDAQ:ADGM), Aldeyra Therapeutics (NASDAQ:ALDX)
- Aldeyra Therapeutics, Inc. (ALDX) Discusses Expansion of RASP Platform Into CNS Diseases and Update on Reproxalap for Dry Eye - Slideshow (NASDAQ:ALDX) 2025-11-16
- Aldeyra expands RASP platform to include neuroinflammatory diseases
- Aldeyra公布ADX-629肝功能试验取得积极结果
- Aldeyra reports positive liver function results for ADX-629 in trial
- Jefferies上调Aldeyra Therapeutics股票目标价至7美元,因FDA接受申请
- Jefferies raises Aldeyra Therapeutics stock price target to $7 on FDA acceptance
- 4 Biotech Stocks Seeing Explosive Momentum Gains - Aldeyra Therapeutics (NASDAQ:ALDX)
- Alkermes stock rating upgraded by RBC Capital on narcolepsy drug potential
- Alkermes任命Joshua Reed为新任首席财务官,将于周一生效
- FDA grants fast track designation for Aldeyra’s eye disease drug
- Aldeyra price target raised to $9 from $6 at Jones Trading on FDA acceptance
- EMA grants orphan designation for Aldeyra’s eye treatment
- Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics
- FDA accepts Aldeyra’s resubmitted NDA for dry eye disease drug
- 5 Small Drug Stocks to Buy Amid Trump's New Tariff Threats
- Aldeyra Therapeutics (ALDX) Upgraded to Strong Buy: What Does It Mean for the Stock?
- Are Medical Stocks Lagging Amgen (AMGN) This Year?
- Aldeyra Stock: Pivotal FDA Decision After Reproxalap’s Chamber Data (NASDAQ:ALDX)
- Aldeyra stock jumps after FDA agreement on cancer drug trial design
常见问题解答
ALDX股票今天的价格是多少?
Aldeyra Therapeutics Inc股票今天的定价为4.63。它在4.22 - 4.74范围内交易,昨天的收盘价为4.41,交易量达到2765。ALDX的实时价格图表显示了这些更新。
Aldeyra Therapeutics Inc股票是否支付股息?
Aldeyra Therapeutics Inc目前的价值为4.63。股息政策取决于公司,而投资者也会关注-7.95%和USD。实时查看图表以跟踪ALDX走势。
如何购买ALDX股票?
您可以以4.63的当前价格购买Aldeyra Therapeutics Inc股票。订单通常设置在4.63或4.93附近,而2765和5.47%显示市场活动。立即关注ALDX的实时图表更新。
如何投资ALDX股票?
投资Aldeyra Therapeutics Inc需要考虑年度范围1.18 - 7.07和当前价格4.63。许多人在以4.63或4.93下订单之前,会比较-9.57%和。实时查看ALDX价格图表,了解每日变化。
Aldeyra Therapeutics Inc股票的最高价格是多少?
在过去一年中,Aldeyra Therapeutics Inc的最高价格是7.07。在1.18 - 7.07内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Aldeyra Therapeutics Inc的绩效。
Aldeyra Therapeutics Inc股票的最低价格是多少?
Aldeyra Therapeutics Inc(ALDX)的最低价格为1.18。将其与当前的4.63和1.18 - 7.07进行比较,可以发现潜在的长期切入点。观看ALDX在图表上的实时走势以获取更多详细信息。
ALDX股票是什么时候拆分的?
Aldeyra Therapeutics Inc历史上曾经历过股票拆分。这些变化在公司行动后的、4.41和-7.95%中可见。
- 前一天收盘价
- 4.41
- 开盘价
- 4.39
- 卖价
- 4.63
- 买价
- 4.93
- 最低价
- 4.22
- 最高价
- 4.74
- 交易量
- 2.765 K
- 日变化
- 4.99%
- 月变化
- -9.57%
- 6个月变化
- -5.51%
- 年变化
- -7.95%
- 实际值
- 预测值
- 前值